✅ Öppen
Ingen deadline angiven
Nationell upphandling PD-(L)1-hämmare 2025
Tidsplan
Publicerad
2025-01-03
Deadline
—
Beskrivning
Tilldelat till: Merck Sharp & Dohme (Sweden) Aktiebolag, AstraZeneca AB, Roche Aktiebolag | Vinnarland: SWE, IRL | Beslutsdatum: 2024-11-13Z
Klassificering
CPV-koder
- 33652000 Cytostatika/cytotoxiska medel och immunmodulerande medel
Procedur
open
Om köparen
Region Stockholm - Serviceförvaltningen har inga öppna upphandlingar på Agentanbud just nu, och 13 annonser i vår data.
Köper oftast: IT-tjänster: konsultverksamhet, programvaruutveckling, Internet och stöd · Medicinsk utrustning, läkemedel och hygienartiklar · Företagstjänster: lagstiftning, marknadsföring, rådgivning, rekrytering, tryckning och säkerhet.
Har oftast tilldelat kontrakt till, enligt 242 tilldelningar i TED: B3 Consulting Group AB (20) · Mediplast AB (11) · SOPRA STERIA SWEDEN AB (10).
Rådata (JSON)
{
"contract-duration-start-date-lot": [
"2025-01-01Z"
],
"title-proc": {
"swe": "Nationell upphandling PD-(L)1-hämmare 2025"
},
"publication-number": "3163-2025",
"contract-conclusion-date": [
"2024-11-30Z",
"2024-11-26Z",
"2024-11-26Z",
"2024-12-04Z",
"2024-11-26Z",
"2024-12-02Z",
"2024-12-04Z"
],
"winner-country": [
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"SWE",
"IRL",
"SWE"
],
"organisation-country-buyer": [
"SWE"
],
"renewal-maximum-lot": [
"12"
],
"framework-agreement-lot": [
"fa-wo-rc"
],
"place-of-performance-country-proc": [
"SWE"
],
"renewal-description-lot": {
"swe": [
"Förlängning är 1 månader"
]
},
"winner-identifier": [
"5561870014",
"5593281933",
"5560117482",
"5560383100",
"5562366343",
"5560929886",
"519550",
"5561027797"
],
"procedure-type": "open",
"classification-cpv": [
"33652000",
"33652000"
],
"publication-date": "2025-01-03+01:00",
"buyer-name": {
"swe": [
"Region Stockholm - Serviceförvaltningen"
]
},
"winner-decision-date": [
"2024-11-13Z",
"2024-11-13Z",
"2024-11-13Z",
"2024-11-13Z",
"2024-11-13Z",
"2024-11-13Z",
"2024-11-13Z"
],
"contract-nature-main-proc": "supplies",
"links": {
"xml": {
"MUL": "https://ted.europa.eu/en/notice/3163-2025/xml"
},
"pdf": {
"BUL": "https://ted.europa.eu/bg/notice/3163-2025/pdf",
"SPA": "https://ted.europa.eu/es/notice/3163-2025/pdf",
"CES": "https://ted.europa.eu/cs/notice/3163-2025/pdf",
"DAN": "https://ted.europa.eu/da/notice/3163-2025/pdf",
"DEU": "https://ted.europa.eu/de/notice/3163-2025/pdf",
"EST": "https://ted.europa.eu/et/notice/3163-2025/pdf",
"ELL": "https://ted.europa.eu/el/notice/3163-2025/pdf",
"ENG": "https://ted.europa.eu/en/notice/3163-2025/pdf",
"FRA": "https://ted.europa.eu/fr/notice/3163-2025/pdf",
"GLE": "https://ted.europa.eu/ga/notice/3163-2025/pdf",
"HRV": "https://ted.europa.eu/hr/notice/3163-2025/pdf",
"ITA": "https://ted.europa.eu/it/notice/3163-2025/pdf",
"LAV": "https://ted.europa.eu/lv/notice/3163-2025/pdf",
"LIT": "https://ted.europa.eu/lt/notice/3163-2025/pdf",
"HUN": "https://ted.europa.eu/hu/notice/3163-2025/pdf",
"MLT": "https://ted.europa.eu/mt/notice/3163-2025/pdf",
"NLD": "https://ted.europa.eu/nl/notice/3163-2025/pdf",
"POL": "https://ted.europa.eu/pl/notice/3163-2025/pdf",
"POR": "https://ted.europa.eu/pt/notice/3163-2025/pdf",
"RON": "https://ted.europa.eu/ro/notice/3163-2025/pdf",
"SLK": "https://ted.europa.eu/sk/notice/3163-2025/pdf",
"SLV": "https://ted.europa.eu/sl/notice/3163-2025/pdf",
"FIN": "https://ted.europa.eu/fi/notice/3163-2025/pdf",
"SWE": "https://ted.europa.eu/sv/notice/3163-2025/pdf"
},
"pdfs": {
"SWE": "https://ted.europa.eu/sv/notice/3163-2025/pdfs"
},
"html": {
"BUL": "https://ted.europa.eu/bg/notice/-/detail/3163-2025",
"SPA": "https://ted.europa.eu/es/notice/-/detail/3163-2025",
"CES": "https://ted.europa.eu/cs/notice/-/detail/3163-2025",
"DAN": "https://ted.europa.eu/da/notice/-/detail/3163-2025",
"DEU": "https://ted.europa.eu/de/notice/-/detail/3163-2025",
"EST": "https://ted.europa.eu/et/notice/-/detail/3163-2025",
"ELL": "https://ted.europa.eu/el/notice/-/detail/3163-2025",
"ENG": "https://ted.europa.eu/en/notice/-/detail/3163-2025",
"FRA": "https://ted.europa.eu/fr/notice/-/detail/3163-2025",
"GLE": "https://ted.europa.eu/ga/notice/-/detail/3163-2025",
"HRV": "https://ted.europa.eu/hr/notice/-/detail/3163-2025",
"ITA": "https://ted.europa.eu/it/notice/-/detail/3163-2025",
"LAV": "https://ted.europa.eu/lv/notice/-/detail/3163-2025",
"LIT": "https://ted.europa.eu/lt/notice/-/detail/3163-2025",
"HUN": "https://ted.europa.eu/hu/notice/-/detail/3163-2025",
"MLT": "https://ted.europa.eu/mt/notice/-/detail/3163-2025",
"NLD": "https://ted.europa.eu/nl/notice/-/detail/3163-2025",
"POL": "https://ted.europa.eu/pl/notice/-/detail/3163-2025",
"POR": "https://ted.europa.eu/pt/notice/-/detail/3163-2025",
"RON": "https://ted.europa.eu/ro/notice/-/detail/3163-2025",
"SLK": "https://ted.europa.eu/sk/notice/-/detail/3163-2025",
"SLV": "https://ted.europa.eu/sl/notice/-/detail/3163-2025",
"FIN": "https://ted.europa.eu/fi/notice/-/detail/3163-2025",
"SWE": "https://ted.europa.eu/sv/notice/-/detail/3163-2025"
},
"htmlDirect": {
"BUL": "https://ted.europa.eu/bg/notice/3163-2025/html",
"SPA": "https://ted.europa.eu/es/notice/3163-2025/html",
"CES": "https://ted.europa.eu/cs/notice/3163-2025/html",
"DAN": "https://ted.europa.eu/da/notice/3163-2025/html",
"DEU": "https://ted.europa.eu/de/notice/3163-2025/html",
"EST": "https://ted.europa.eu/et/notice/3163-2025/html",
"ELL": "https://ted.europa.eu/el/notice/3163-2025/html",
"ENG": "https://ted.europa.eu/en/notice/3163-2025/html",
"FRA": "https://ted.europa.eu/fr/notice/3163-2025/html",
"GLE": "https://ted.europa.eu/ga/notice/3163-2025/html",
"HRV": "https://ted.europa.eu/hr/notice/3163-2025/html",
"ITA": "https://ted.europa.eu/it/notice/3163-2025/html",
"LAV": "https://ted.europa.eu/lv/notice/3163-2025/html",
"LIT": "https://ted.europa.eu/lt/notice/3163-2025/html",
"HUN": "https://ted.europa.eu/hu/notice/3163-2025/html",
"MLT": "https://ted.europa.eu/mt/notice/3163-2025/html",
"NLD": "https://ted.europa.eu/nl/notice/3163-2025/html",
"POL": "https://ted.europa.eu/pl/notice/3163-2025/html",
"POR": "https://ted.europa.eu/pt/notice/3163-2025/html",
"RON": "https://ted.europa.eu/ro/notice/3163-2025/html",
"SLK": "https://ted.europa.eu/sk/notice/3163-2025/html",
"SLV": "https://ted.europa.eu/sl/notice/3163-2025/html",
"FIN": "https://ted.europa.eu/fi/notice/3163-2025/html",
"SWE": "https://ted.europa.eu/sv/notice/3163-2025/html"
}
},
"winner-name": {
"swe": [
"Merck Sharp & Dohme (Sweden) Aktiebolag",
"AstraZeneca AB",
"Roche Aktiebolag",
"GlaxoSmithKline AB",
"Bristol-Myers Squibb Aktiebolag",
"Regeneron Ireland DAC",
"Merck Aktiebolag"
]
},
"contract-duration-end-date-lot": [
"2025-12-31Z"
],
"notice-title": {
"hun": "Svédország – Daganatellenes és immunmodulátor szerek – Nationell upphandling PD-(L)1-hämmare 2025",
"lav": "Zviedrija – Antineoplastiskie līdzekļi un imūnmodulatori – Nationell upphandling PD-(L)1-hämmare 2025",
"swe": "Sverige – Cytostatika/cytotoxiska medel och immunmodulerande medel – Nationell upphandling PD-(L)1-hämmare 2025",
"gle": "An tSualainn – Antineoplastic and immunomodulating agents – Nationell upphandling PD-(L)1-hämmare 2025",
"ell": "Σουηδία – Αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα – Nationell upphandling PD-(L)1-hämmare 2025",
"spa": "Suecia – Agentes antineoplásicos e inmunomoduladores – Nationell upphandling PD-(L)1-hämmare 2025",
"est": "Rootsi – Antineoplastilised ja immuunmoduleerivad ained – Nationell upphandling PD-(L)1-hämmare 2025",
"nld": "Zweden – Antineoplastische en immunomodulerende middelen – Nationell upphandling PD-(L)1-hämmare 2025",
"fin": "Ruotsi – Solunsalpaajat ja sytostaatit sekä immunomodulantit – Nationell upphandling PD-(L)1-hämmare 2025",
"pol": "Szwecja – Środki przeciwnowotworowe i immunomodulacyjne – Nationell upphandling PD-(L)1-hämmare 2025",
"hrv": "Švedska – Antineoplastični lijekovi i imunomodulatori – Nationell upphandling PD-(L)1-hämmare 2025",
"ces": "Švédsko – Antineoplastika a imunomodulátory – Nationell upphandling PD-(L)1-hämmare 2025",
"dan": "Sverige – Antineoplastiske og immunmodulerende midler – Nationell upphandling PD-(L)1-hämmare 2025",
"ron": "Suedia – Antineoplazice şi imunomodulatoare – Nationell upphandling PD-(L)1-hämmare 2025",
"por": "Suécia – Antineoplásicos e imunomoduladores – Nationell upphandling PD-(L)1-hämmare 2025",
"slk": "Švédsko – Antineoplastické a imunomodulačné činidlá – Nationell upphandling PD-(L)1-hämmare 2025",
"fra": "Suède – Antinéoplasiques et immunomodulateurs – Nationell upphandling PD-(L)1-hämmare 2025",
"mlt": "L-Iżvezja – Aġenti ta' l-antineoplastika u ta' l-immunomodulaturi – Nationell upphandling PD-(L)1-hämmare 2025",
"deu": "Schweden – Antineoplastische und immunmodulierende Mittel – Nationell upphandling PD-(L)1-hämmare 2025",
"lit": "Švedija – Antinavikiniai vaistai ir imunomoduliatoriai – Nationell upphandling PD-(L)1-hämmare 2025",
"ita": "Svezia – Agenti antineoplastici e immunomodulatori – Nationell upphandling PD-(L)1-hämmare 2025",
"bul": "Швeция – Антинеопластични средства и имуномодулатори – Nationell upphandling PD-(L)1-hämmare 2025",
"slv": "Švedska – Zdravila z delovanjem na novotvorbe in imunomodulatorji – Nationell upphandling PD-(L)1-hämmare 2025",
"eng": "Sweden – Antineoplastic and immunomodulating agents – Nationell upphandling PD-(L)1-hämmare 2025"
},
"buyer-city": {
"mul": [
"STOCKHOLM"
]
}
}